{{Rsnum
|rsid=1007888
|Gene=NUBPL
|Chromosome=22
|position=23898914
|Orientation=plus
|GMAF=0.4518
|Gene_s=NUBPL
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 39.8 | 49.6 | 10.6
| HCB | 19.0 | 57.7 | 23.4
| JPT | 23.9 | 49.6 | 26.5
| YRI | 2.0 | 35.4 | 62.6
| ASW | 10.5 | 43.9 | 45.6
| CHB | 19.0 | 57.7 | 23.4
| CHD | 19.3 | 56.9 | 23.9
| GIH | 41.6 | 46.5 | 11.9
| LWK | 0.9 | 27.3 | 71.8
| MEX | 25.9 | 51.7 | 22.4
| MKK | 1.3 | 28.2 | 70.5
| TSI | 26.7 | 46.5 | 26.7
| HapMapRevision=28
}}[[rs1007888(C;C)]] was associated with an increased risk of [[type-2 diabetes]] in women [hazard ratio (95% CI) 1.74 (1.02-2.97)], but not in men [1.17 (0.75-1.81)]. {{PMID|17712545}}

{{PMID Auto
|PMID=21512965
|Title=Genetic Variation in Macrophage Migration Inhibitory Factor Associated with Gestational Diabetes Mellitus and Metabolic Syndrome
}}

{{PMID|17585860|OA=1
}} Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations.

{{PMID|18853133|OA=1
}} Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes.

{{PMID|19167373}} The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.

{{PMID|20169173|OA=1
}} Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.

{{PMID|20616999|OA=1
}} Usefulness of Mendelian randomization in observational epidemiology.

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}